a year ago
RVMD
AnalystsPeter LawsonPeter Lawson's Stock Forecasts
AnalystsPeter Lawson
Analyst Ranking
Bottom 4%
#4835 out of 5020 analysts
Average Return
-6.58%
Win Rate
35%35 out of 101
Risk vs Reward
Poor
Good
Peter Lawson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immunogen IncIMGN | +214.57% | $5.01 | $15.76 | 2022-11-15 - 2023-11-14 | Strong Buy |
Immunogen IncIMGN | +187.55% | $5.46 | $15.70 | 2022-09-09 - 2023-09-08 | Strong Buy |
Immunomedics IncIMMU | +171.17% | $32.40 | $87.86 | 2020-05-05 - 2020-10-22 | Strong Buy |
Fate Therapeutics IncFATE | +170.37% | $30.75 | $83.14 | 2020-03-04 - 2021-03-04 | Strong Buy |
Syndax Pharmaceuticals IncSNDX | +100.18% | $11.28 | $22.58 | 2020-03-04 - 2021-03-04 | Strong Buy |
Peter Lawson Analyst Color
Get additional color on Peter Lawson's coverage of popular stocks
2 years ago
MGNX
2 years ago
ARVN
2 years ago
MGNX
2 years ago
SWTX
2 years ago
EXEL
2 years ago
SWTX
2 years ago
SNDX
2 years ago
IMGN
Peter Lawson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ideaya Biosciences IncIDYA | 1 | Strong Buy | $40.00 | +63.67% | Initiates Coverage On | 15 days ago |
Schrodinger IncSDGR | 1 | Strong Buy | $25.00 | +31.37% | Initiates Coverage On | a month ago |
Replimune Group IncREPL | 4 | Hold | $3.00 | -47.46% | Downgrades | 2 months ago |
Exelixis IncEXEL | 6 | Hold | $40.00 | -1.09% | Maintains | 2 months ago |
Macrogenics IncMGNX | 9 | Strong Buy | $3.00 | +96.08% | Maintains | 4 months ago |
Fate Therapeutics IncFATE | 4 | Strong Buy | $2.00 | +110.53% | Maintains | 4 months ago |
Adaptimmune Therapeutics PLCADAP | 3 | Strong Sell | $0.46 | +467.90% | Maintains | 4 months ago |
Karyopharm Therapeutics IncKPTI | 3 | Strong Buy | $10.00 | +64.47% | Maintains | 4 months ago |
Iovance Biotherapeutics IncIOVA | 6 | Strong Buy | $4.00 | +80.18% | Maintains | 4 months ago |
Xencor IncXNCR | 2 | Strong Sell | $6.00 | -35.14% | Maintains | 4 months ago |
Kura Oncology IncKURA | 1 | Strong Buy | $11.00 | +35.97% | Maintains | 5 months ago |
Arvinas IncARVN | 8 | Strong Buy | $16.00 | +110.25% | Maintains | 5 months ago |
Bicycle Therapeutics PLCBCYC | 2 | Strong Buy | $15.00 | +116.76% | Maintains | 5 months ago |
Springworks Therapeutics IncSWTX | 4 | Hold | $47.00 | +0.02% | Downgrades | 5 months ago |
Arcus Biosciences IncRCUS | 7 | Strong Buy | $14.00 | +16.38% | Maintains | 5 months ago |
Biomea Fusion IncBMEA | 5 | Hold | $3.00 | +53.06% | Maintains | 6 months ago |
Tscan Therapeutics IncTCRX | 2 | Strong Buy | $3.00 | +87.50% | Maintains | 6 months ago |
Geron CorpGERN | 1 | Strong Buy | $4.00 | +214.96% | Maintains | 7 months ago |
Revolution Medicines IncRVMD | 3 | Strong Buy | $60.00 | +36.96% | Maintains | a year ago |
Relay Therapeutics IncRLAY | 5 | Strong Buy | $17.00 | N/A | Maintains | a year ago |
Syndax Pharmaceuticals IncSNDX | 3 | Strong Buy | $33.00 | N/A | Maintains | a year ago |
Exscientia PLCEXAI | 4 | Hold | $5.00 | N/A | Downgrades | a year ago |
Immunocore Holdings PLCIMCR | 2 | Strong Buy | $66.00 | N/A | Maintains | a year ago |
Blueprint Medicines CorpBPMC | 9 | Hold | $105.00 | N/A | Maintains | a year ago |
Nurix Therapeutics IncNRIX | 2 | Strong Buy | $31.00 | N/A | Maintains | a year ago |
Tango Therapeutics IncTNGX | 1 | Strong Buy | $13.00 | N/A | Maintains | a year ago |
Deciphera Pharmaceuticals IncDCPH | 6 | Hold | $26.00 | N/A | Upgrades | a year ago |
Immunogen IncIMGN | 5 | Hold | $31.00 | N/A | Downgrades | 2 years ago |
Prelude Therapeutics IncPRLD | 4 | Hold | $5.00 | N/A | Maintains | 2 years ago |
Neximmune IncNEXI | 2 | Strong Buy | $50.00 | N/A | Maintains | 3 years ago |
Cytomx Therapeutics IncCTMX | 3 | Strong Buy | $3.50 | N/A | Maintains | 3 years ago |
Illumina IncILMN | 1 | Strong Sell | $365.00 | N/A | Maintains | 4 years ago |
Agios Pharmaceuticals IncAGIO | 2 | Strong Buy | $46.00 | N/A | Upgrades | 5 years ago |
Immunomedics IncIMMU | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 5 years ago |
Epizyme IncEPZM | 1 | Strong Buy | $33.00 | N/A | Initiates Coverage On | 6 years ago |
Nektar TherapeuticsNKTR | 1 | Strong Buy | $450.00 | N/A | Initiates Coverage On | 6 years ago |
Tesaro IncTSRO | 1 | Hold | $75.00 | N/A | Downgrades | 7 years ago |
Celyad Oncology SaCYADY | 1 | Strong Buy | $49.00 | N/A | Initiates Coverage On | 7 years ago |
Editas Medicine IncEDIT | 1 | Strong Buy | $45.00 | N/A | Upgrades | 8 years ago |
Crispr Therapeutics AgCRSP | 1 | Strong Buy | $45.00 | N/A | Upgrades | 8 years ago |
Juno Therapeutics IncJUNO | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Affimed NvAFMDQ | 1 | Strong Buy | $70.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.